MATTHEW ALEXANDER: Open Payments
NPI 1427715424 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,923 in 77 payments from 20 companies in 2025. Trend: 2023 $1,298 · 2024 $2,800 · 2025 $1,923
Food & beverage: $1,882Education: $25Consulting: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $335 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $237 |
| Ionis Pharmaceuticals, Inc. | 4 | $201 |
| GENZYME CORPORATION | 7 | $184 |
| Pharming Healthcare, Inc. | 8 | $167 |
| CSL Behring | 4 | $95 |
| Amgen Inc. | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| BioCryst US Sales Co., LLC | 4 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
Products named: NEFFY, DUPIXENT, AIRSUPRA, RUCONEST, DAWNZERA, TEZSPIRE, ORLADEYO, XOLAIR.
Industry payments across MD — which companies pay providers there.
